KOSPIConstruction & Materials023960

SC Engineering

₩965 0.00%2026-11-18 close
Market Cap
₩36.7B
Turnover
₩3,394,922
Volume
3.6K
Shares out.
38M
PER
—
PBR
1.0×
EPS
-₩273
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Semiconductor plant orders grow as losses persist

Semiconductor projects reached 49.5% of orders by the end of August 2026, but operating losses have run for three straight quarters through the third quarter of 2026, making earnings recovery the key question.

  1. 1

    On a disclosed basis, operating results swung from an operating profit of KRW 6.56 billion in 2024 to an operating loss of KRW 4.96 billion in 2025.

  2. 2

    Operating losses have persisted for three quarters from the first quarter to the third quarter of 2026, and the net loss attributable to controlling shareholders over the last four quarters totals KRW 10.6 billion.

  3. 3

    The semiconductor share of order value rose from 31.9% in 2021 to 49.5% at the end of August 2026, and the company says semiconductor projects make up 76.5% of its total backlog.

  4. 4

    Two semiconductor materials EPC contracts were announced in 2026, worth KRW 27.9 billion in May and KRW 9.7 billion in August, and press reports put cumulative contract value with QNITY at KRW 37.7 billion.

  5. 5

    Because the last four quarters show net losses, the price-to-earnings ratio is not calculable, while the price-to-book ratio sits close to net asset value.

02

Business structure

SC Engineering was founded in 1971 and listed on the KOSPI market in 1997 as a comprehensive engineering company. Its core business is engineering, procurement and construction (EPC) for industrial plants in fine chemicals, pharmaceuticals, food, environment and energy.

According to an Alphasquare breakdown based on 2025 results, industrial plant construction accounts for 88.03% of revenue, bio-collagen medical devices for 10.62% and the Switch On health supplement for 0.93%.

Press reports say its EPC unit mainly handles small and mid-sized projects that large domestic builders do not take on. The semiconductor share of order value rose from 31.9% in 2021 to 49.5% at the end of August 2026, and the company says semiconductor projects make up 76.5% of its total backlog.

Key clients include DuPont Specialty Materials Korea, which is building a specialty chemical materials plant for semiconductor processes at its Cheonan site, and QNITY, along with hydrogen plant and TPC plant customers.

The group became a member of the Ban Do group affiliate structure in February 2026, and Song Han-gyu was appointed CEO that month. Its bio-collagen subsidiary Cellontech is expanding its overseas sales network.

New businesses include modular plants and smart factories, and the company is widening revenue into health functional foods, cosmetics and regenerative medical devices.

It overlaps with large plant contractors such as Samsung E&A and Hyundai Engineering & Construction, but it is strengthening its position in mid-sized projects and semiconductor materials, parts and equipment EPC.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩48.1B-₩5.2B−10.9%
2025Q4₩44.7B₩900M2.1%
2026Q1₩19.3B-₩1.8B−9.5%
2026Q2₩13.8B-₩4B−28.8%
2026Q3₩21B-₩3.1B−14.6%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩137.2B₩7.8B₩5.5B5.7%13.2%158.2%
2023₩136B₩1B-₩2.4B0.7%−6.1%154.4%
2024₩179.9B₩6.6B₩3.7B3.6%8.1%143.9%
2025₩172.3B-₩5B-₩4.8B−2.9%−10.1%188.8%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-14

04

Earnings analysis

Annual revenue fell from KRW 137.2 billion in 2022 to KRW 136 billion in 2023, a 0.9% decline, then rose to KRW 179.9 billion in 2024, up 32.3%. Among 2022 to 2025, 2024 was the year with the largest revenue, and 2025 revenue of KRW 172.3 billion declined 4.2% from the prior year.

Operating profit went from KRW 7.78 billion in 2022 to KRW 983 million in 2023, down 87.4%, then to KRW 6.56 billion in 2024, up 567.7%, before swinging to an operating loss of KRW 4.96 billion in 2025. The operating margin moved from 5.7% in 2022 to 0.7% in 2023 and 3.6% in 2024, and was -2.9% in 2025.

For 2024, the company attributed the improvement to strong performance across its EPC business, healthcare business and bio business at subsidiary Cellontech, according to a February 2025 press report.

For the 2025 swing to a loss, the company cited higher subcontracting costs that raised the cost of sales ratio, along with higher commission and advertising expenses, in its February 2026 disclosure.

Net income attributable to controlling shareholders was KRW 5.46 billion in 2022, a net loss of KRW 2.36 billion in 2023, a profit of KRW 3.72 billion in 2024, and a net loss of KRW 4.75 billion in 2025.

Net income including non-controlling interests was KRW 7.14 billion in 2022, larger than the controlling-shareholder figure that year. The debt-to-equity ratio fell from 158.2% in 2022 and 143.9% in 2024 but rose to 188.8% in 2025, when total liabilities were KRW 89.1 billion against total equity of KRW 47.2 billion.

Operating cash flow was KRW 7.65 billion in 2022, negative KRW 2.99 billion in 2023, KRW 6.38 billion in 2024 and KRW 3.82 billion in 2025.

On a quarterly basis, revenue was KRW 48.1 billion in the third quarter of 2025, KRW 44.7 billion in the fourth quarter, KRW 19.3 billion in the first quarter of 2026, KRW 13.8 billion in the second quarter and KRW 21 billion in the third quarter.

Third-quarter 2026 revenue rose 52.1% from the previous quarter but fell 56.2% from a year earlier.

Operating results were an operating loss of KRW 5.23 billion in the third quarter of 2025, an operating profit of KRW 948 million in the fourth quarter, and operating losses of KRW 1.84 billion, KRW 3.98 billion and KRW 3.07 billion in the first three quarters of 2026.

Net income attributable to controlling shareholders was a loss of KRW 4.69 billion in the third quarter of 2025, a profit of KRW 1.28 billion in the fourth quarter, and losses of KRW 3.1 billion, KRW 4.97 billion and KRW 3.77 billion in the first three quarters of 2026.

The net loss attributable to controlling shareholders over the last four quarters totals KRW 10.6 billion. Because EPC revenue is recognized by construction progress, according to a October 2026 Seoul Economic TV report, the pace at which orders convert into revenue drives quarterly volatility.

05

Industry analysis

Demand for semiconductor plant EPC is expected to expand as AI-driven chip demand translates into capacity additions, according to a Seoul Economic TV report from October 2026. Beyond new fab construction and line expansions, investment by materials, parts and equipment suppliers is widening the pool of plant orders.

Statistics Korea data for July 2026 showed total construction orders down 1.1% month on month, while civil engineering, which includes semiconductor plant work, rose 18.5%.

Semiconductor plants require strict design and construction quality, safety management and on-time completion, so track record is cited as a driver of follow-on order competitiveness.

The company says its group affiliation has strengthened cooperation on funding and technology and expanded its access to semiconductor project bids. However, with 76.5% of its backlog tied to semiconductors, the company is exposed to swings in chip capital spending cycles.

Compared with large builders such as Samsung E&A and Hyundai Engineering & Construction, the company focuses on mid-sized plants and materials, parts and equipment EPC. In hydrogen, completion of a hydrogen plant for K&D Energen in July 2026 added to its project record.

In medical devices, overseas expansion remains the main task, and a 2025 press report said the company had secured minimum order commitments above KRW 120 billion in overseas markets.

06

Outlook

Confirmed contract flow includes a KRW 27.9 billion semiconductor materials EPC contract announced in May 2026 and an additional KRW 9.7 billion contract in August 2026. The May contract runs from May 6, 2026 to November 30, 2027, about 18 months.

In May, the company said it expected three further contracts within the year that would raise total contract value. According to press reports, the August addition lifted cumulative contract value with QNITY to KRW 37.7 billion.

The company says it is bidding on advanced-industry projects in semiconductors and hydrogen and will focus on securing quality orders in the second half.

In early 2025 the company said carried-over backlog had nearly doubled from KRW 89 billion the prior year, but 2025 revenue still fell 4.2%, showing that the pace of converting backlog into revenue shapes results.

The company has cited expanding overseas sales and boosting production capacity at its medical device subsidiary as medium-term tasks. The Switch On dietary fiber product launched in September 2026.

The next checkpoints are the fourth-quarter 2026 preliminary results and the year-end backlog and operating margin in the 2026 annual report.

07

Valuation

PER
—
PBR
1.0×
ROE
-26.3%
EPS
-₩273
BPS
₩962
Dividend per share
₩0

Because the last four quarters show net losses attributable to controlling shareholders, the price-to-earnings ratio cannot be calculated. With no usable earnings base, valuation has to be read through net assets and operating metrics.

The price-to-book ratio sits close to net asset value and is above the construction sector average on an Alphasquare basis for 2025. The dividend yield is below the sector average, and no shareholder return through dividends is confirmed.

The debt-to-equity ratio at year-end 2025 is lower than the sector average on the same 2025 annual basis but has risen from 2024. The operating margin was -2.9% in 2025, a loss-making level, though still above the sector average operating margin. Market capitalization ranks in the lower part of the construction sector.

The starting point for interpreting valuation is earnings recovery, and whether the pattern of three straight operating loss quarters after the fourth-quarter 2025 profit changes in the next reported results.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-14

08

Bull factors

Shift toward semiconductor plant orders

Semiconductor projects rose from 31.9% of order value in 2021 to 49.5% at the end of August 2026. The company says 76.5% of its total backlog is semiconductor-related. The May 2026 KRW 27.9 billion and August KRW 9.7 billion contracts cover full EPC scope for a specialty chemical plant in Cheonan. If chip capital spending keeps expanding, this mix could support further order growth.

Narrowing quarterly operating losses

The company posted a KRW 948 million operating profit in the fourth quarter of 2025. The operating loss narrowed from KRW 3.98 billion in the second quarter of 2026 to KRW 3.07 billion in the third quarter. Third-quarter revenue of KRW 21 billion rose 52.1% from the prior quarter. If this pattern continues, the narrowing loss supports a recovery narrative.

Growth options from new businesses and subsidiary

Completion of a hydrogen plant for K&D Energen in July 2026 added to the EPC track record in hydrogen. A 2025 press report said subsidiary Cellontech had secured minimum order commitments above KRW 120 billion in overseas markets. Operating cash flow stayed positive at KRW 3.82 billion in 2025. Whether new businesses can offset core losses is the point to watch.

09

Bear factors

Persistent quarterly operating losses

Operating losses have run for three straight quarters through the third quarter of 2026, with losses of KRW 1.84 billion, KRW 3.98 billion and KRW 3.07 billion. The net loss attributable to controlling shareholders over the last four quarters totals KRW 10.6 billion. The swing to a 2025 annual operating loss of KRW 4.96 billion has carried into 2026.

Shrinking revenue base

Quarterly revenue was KRW 19.3 billion in the first quarter of 2026, KRW 13.8 billion in the second and KRW 21 billion in the third, compared with KRW 48.1 billion in the third quarter of 2025. Third-quarter 2026 revenue fell 56.2% from a year earlier. Annual revenue also declined 4.2% to KRW 172.3 billion in 2025. A slow pace of conversion from orders to revenue could prolong the loss structure.

Rising financial leverage

The debt-to-equity ratio rose from 158.2% in 2022 to 188.8% in 2025. Total liabilities of KRW 89.1 billion at year-end 2025 exceed total equity of KRW 47.2 billion. If net losses attributable to controlling shareholders continue, the capital cushion narrows. Rising financial burden is a bearish factor that offsets the bullish order story.

10

Risk factors

Customer and sector concentration risk

With 76.5% of backlog tied to semiconductors, the company is sensitive to the chip capital spending cycle. A small number of semiconductor and materials clients dominate orders, so delays or plan changes could push back order and revenue timing. The May 2026 contract runs to November 30, 2027, so construction progress management matters.

Cost and profitability risk

The company attributed the 2025 swing to a loss to higher subcontracting costs that pushed up the cost of sales ratio, along with higher commission and advertising expenses. In a structure that relies on subcontractors, cost control slippage can quickly weigh on margins. The operating margin was -2.9% in 2025.

Financial and ownership structure risk

After the February 2026 affiliation with the Ban Do group, the CEO was replaced and the management setup changed. During an ownership transition, business direction and investment plans can shift. With the debt-to-equity ratio up to 188.8% in 2025, the need for additional funding is also a point to weigh.

11

What to watch next

  1. End of December 2026

    Check for further contract disclosures on the Cheonan plant project, which the company said in May 2026 would include three additional contracts within the year, and changes in cumulative contract value.

  2. Early February 2027

    Fourth-quarter 2026 preliminary results, which may come around the same period as the 2025 preliminary disclosure on February 6, 2026. Watch whether the streak of three straight operating loss quarters ends.

  3. End of March 2027

    Around the statutory filing deadline for the 2026 annual report. Check full-year revenue, operating margin, debt-to-equity ratio and year-end backlog on a disclosed basis.

  4. November 30, 2027

    End of the contract period for the DuPont Specialty Materials Korea Cheonan plant project. Watch construction progress and completion timing for their effect on revenue recognition.

12

Overall view

SC Engineering is shifting its order mix toward semiconductor plant EPC. Semiconductor projects accounted for 49.5% of order value at the end of August 2026, and the company says 76.5% of its backlog is semiconductor-related.

The KRW 27.9 billion contract in May 2026 and the KRW 9.7 billion addition in August, with cumulative value of KRW 37.7 billion per press reports, show that order flow is active.

On the disclosed numbers, however, the company swung to a KRW 4.96 billion operating loss in 2025, and operating losses have continued for three straight quarters through the third quarter of 2026.

The net loss attributable to controlling shareholders over the last four quarters totals KRW 10.6 billion, and third-quarter 2026 revenue fell 56.2% from a year earlier. The debt-to-equity ratio rose to 188.8% in 2025.

Bullish factors are the order mix and narrowing quarterly losses, while bearish factors are continuing operating losses, shrinking revenue and financial burden. The next checkpoints are the fourth-quarter 2026 preliminary results and the operating margin and backlog in the 2026 annual report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. alphasquare.co.kr
  2. etoday.co.kr
  3. etoday.co.kr
  4. m.sedaily.com
  5. m.news.nate.com
  6. bloter.net
  7. news.nate.com
  8. v.daum.net
  9. news.nate.com
  10. edaily.co.kr
  11. hankyung.com
  12. thebell.co.kr
  13. mt.co.kr
  14. mt.co.kr
  15. dealsite.co.kr
  16. sentv.co.kr
  17. etoday.co.kr
  18. supple.kr

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis